omed pt 2 > COPD notes > Flashcards

COPD notes Flashcards

(317 cards)

Study These Flashcards
1
Q

What does COPD stand for?

A

Chronic obstructive pulmonary disease

COPD is an umbrella term for various clinical entities that result in airflow limitation that is not fully reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main diseases encompassed by COPD?

A

Chronic bronchitis, cystic fibrosis, bronchiectasis, emphysema

COPD usually refers to a mixture of chronic bronchitis and emphysema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define chronic bronchitis.

A

Characterized by excessive secretion of bronchial mucus resulting in obstruction of small airways

Manifested by productive cough for 3 months or more in at least 2 consecutive years in the absence of other diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is emphysema?

A

Characterized by loss of lung elasticity and destruction of lung parenchyma with abnormal permanent enlargement of air spaces

Destruction occurs distal to the terminal bronchiole and involves the walls (interalveolar septa) without obvious fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of adults in the United States are affected by COPD?

A

14%

This statistic applies to adults aged 40 to 79 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the rank of COPD as a cause of death in the United States?

A

Fourth

COPD is one of the leading causes of death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: COPD is fully reversible.

A

False

COPD results in airflow limitation that is not fully reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fill in the blank: COPD usually refers to a mixture of __________ and emphysema.

A

Chronic bronchitis

This is a key characteristic of COPD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What risk factor accounts for more than 85% of the risk of developing COPD in the USA?

A

Cigarette smoking

Age also contributes significantly to the risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What percentage of cigarette smokers develop clinically significant COPD?

A

About 15%

This is despite the high risk associated with smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does cigarette smoking affect COPD mortality and respiratory symptoms?

A

Higher COPD mortality, higher prevalence and incidence of productive cough, and other respiratory symptoms

Spirometrically shown airway obstruction is related to smoking dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the relationship between air pollution and COPD compared to cigarette smoking?

A

Air pollution plays a minor role compared with cigarette smoking

The exact role of air pollution in producing COPD is not precisely understood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What indoor conditions may lead to the development of COPD?

A

Using solid fuels for cooking and heating without adequate ventilation

This can result in high levels of indoor air pollution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What occupational exposures are associated with increased prevalence of chronic airflow obstruction?

A

Airborne chemical vapors, fumes, or biologically inactive dusts

Examples include dusts from cotton, cadmium, coal, and silica.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the interaction between cigarette smoking and exposure to hazardous dust?

A

It further increases the frequency of COPD

However, smoking effects are much greater than occupational effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What condition may predispose smokers to the development of airway obstruction?

A

Hyper-responsive airways

This may be due to an allergic-induced state or nonspecific airway hyper-responsiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the main role of alpha1-protease inhibitor (API) in the body?

A

Inhibition of neutrophil elastase

API is a serum protein normally found in the lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does homozygous API deficiency result in?

A

Premature development of severe emphysema

This typically occurs between ages 25 and 50 and is rare, accounting for less than 1% of COPD patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is emphysema characterized by pathologically?

A

Dilatation of the acinar air spaces due to destruction of the interalveolar septa

The destruction is thought to be due to proteolytic enzymes released from leukocytes during inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What causes the destruction of the interalveolar septa in emphysema?

A

Proteolytic enzymes released from leukocytes during inflammation

These enzymes lead to the breakdown of the septa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is one consequence of the septal destruction in emphysema?

A

Reduced elasticity of lung tissue

This restricts air flow to the respiratory portion of the lung and causes airways to collapse during expiration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What happens to air in the dilated acinar spaces during expiration in emphysema?

A

Air enters but can’t get back out due to no elastic recoil

The patient must force expiration, raising intrathoracic pressure and further constricting bronchioles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is reduced as a consequence of septal destruction in emphysema?

A

Surface area and amount of capillaries available for gas exchange

This reduction impacts the efficiency of gas exchange in the lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the clinical consequences of emphysema?

A

Progressive dyspnea, hypoxemia, and hypoxia

Dyspnea refers to difficulty in breathing, hypoxemia indicates low blood oxygen levels, and hypoxia refers to low tissue oxygen levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What occurs in advanced emphysema related to pulmonary circulation?
Increased pulmonary artery pressure (pulmonary hypertension) ## Footnote This condition can lead to cor pulmonale.
26
What is cor pulmonale?
Dysfunction or failure of the right ventricle of the heart caused by a primary disorder of the respiratory system ## Footnote It is a complication that can arise from chronic lung diseases such as emphysema.
27
What are the two major forms of emphysema classified by?
The site of involvement
28
What is the most common form of emphysema?
Centriacinar (centrilobular) emphysema
29
Centriacinar emphysema is _______ times more common than panacinar emphysema.
20
30
In which lung lobes are lesions more common and severe in centriacinar emphysema?
Upper lung lobes, particularly in the apical segments
31
What part of the acini is affected in centriacinar emphysema?
Central or proximal parts formed by respiratory bronchioles
32
What is spared in centriacinar emphysema?
Distal alveoli
33
Centriacinar emphysema occurs predominantly in which gender?
Men
34
What is the most frequent association of centriacinar emphysema?
Cigarette smoking
35
Where does panacinar emphysema occur more commonly?
Lower lung zones
36
What is the distinctive feature of panacinar emphysema?
Acini are uniformly enlarged from the respiratory bronchiole to the terminal blind alveoli
37
Panacinar emphysema occurs predominantly in which age group?
Older persons
38
What conditions is panacinar emphysema associated with? (List at least two)
* Scoliosis * Silicosis * Marfan syndrome
39
Is panacinar emphysema strongly associated with cigarette smoking?
No
40
Which type of emphysema is seen in alpha1-antitrypsin deficiency?
Panacinar emphysema
41
What is chronic bronchitis primarily attributed to?
Long-standing irritation of the airways from airway irritants, especially cigarette smoke ## Footnote Chronic bronchitis is often seen in smokers due to prolonged exposure to harmful substances.
42
What is the distinctive feature of chronic bronchitis?
Hypersecretion of mucus, beginning in the large airways ## Footnote This hypersecretion is a key characteristic that differentiates chronic bronchitis from other respiratory conditions.
43
What pathologic changes occur in chronic bronchitis?
* Hypertrophy of mucous glands * Increase in mucin-secreting goblet cells * Increased mucus viscosity and volume ## Footnote These changes contribute to the symptoms and complications associated with chronic bronchitis.
44
What impairment is caused by increased mucus viscosity and volume in chronic bronchitis?
Impairment of pulmonary defense mechanisms characterized by a decrease in ciliary activity and interference with normal pulmonary phagocytic cell activity ## Footnote This impairment can lead to further respiratory issues.
45
Which inflammatory cell populations increase in the airway wall in chronic bronchitis?
* Macrophages * Neutrophils * Lymphocytes ## Footnote The presence of these inflammatory cells indicates ongoing inflammation in the airways.
46
What may account for the significant airflow obstruction seen in chronic bronchitis?
Retained mucus secretions plus inflammation ## Footnote This obstruction can lead to difficulty in breathing and reduced lung function.
47
Why do patients with chronic bronchitis experience an increased frequency of lower respiratory infections?
Impairment of pulmonary defense mechanisms ## Footnote This impairment reduces the lungs' ability to fight off infections effectively.
48
What may be completely absent early in the course of COPD?
Clinical findings ## Footnote This highlights the initial asymptomatic nature of COPD.
49
As COPD progresses, what symptoms typically emerge?
Excessive cough, sputum production, and shortness of breath (dyspnea) ## Footnote These symptoms reflect the worsening condition of the patient.
50
At what age do patients with COPD typically present?
Fifth or sixth decade of life ## Footnote This indicates the common age range for the onset of COPD symptoms.
51
What type of cough may be present initially in COPD patients?
Morning cough (smokers cough) ## Footnote This cough often progresses to a chronic cough as the disease worsens.
52
What are the two concomitant disorders associated with COPD?
Chronic bronchitis and emphysema ## Footnote Patients may exhibit symptoms of either disorder or a combination of both.
53
What characterizes the cough in COPD patients as the disease progresses?
Becomes chronic and often productive of large amounts of sputum ## Footnote This change indicates an increase in the severity of the condition.
54
True or False: Most patients with COPD have pathologic evidence of only one disorder.
False ## Footnote Most patients exhibit evidence of both chronic bronchitis and emphysema.
55
What are common signs and symptoms of advanced COPD?
Combinations of cyanosis, chronic productive cough, tachypnea, tachycardia, and fatigue ## Footnote These symptoms indicate worsening airflow obstruction.
56
What is dyspnea in the context of COPD?
A persistent and progressive difficulty in inspiring due to airway obstruction ## Footnote Dyspnea is the major cause of disability in COPD.
57
How does the degree of dyspnea correlate with FEV1 in COPD patients?
It generally correlates inversely with the FEV1 ## Footnote Lower FEV1 values indicate greater difficulty in breathing.
58
What is pursed-lip breathing?
Inhaling through the nose and slowly exhaling through the mouth ## Footnote This technique is often used by patients with COPD to ease breathing.
59
What are the characteristics of chronic sputum production in COPD?
Patients frequently produce sputum that is typically chronic and may be productive ## Footnote Sputum production is a common symptom among COPD patients.
60
What are the chest wall abnormalities associated with advanced COPD?
Hyperinflation, increased anteroposterior diameter (barrel chest), and protruding abdomen ## Footnote These abnormalities result from long-term changes in lung function.
61
What is hyperinflation of the lungs in COPD?
An increase in total lung capacity reflecting loss of lung elastic recoil and limitation of expiratory flow ## Footnote Hyperinflation is a hallmark of COPD.
62
Which muscles are typically used for respiration in advanced COPD?
Accessory muscles ## Footnote Patients may rely on accessory muscles due to difficulty breathing.
63
Fill in the blank: Dyspnea is characterized as difficulty in _______.
inspiring
64
True or False: The symptoms of advanced COPD can include wheezing.
True
65
What is the significance of tachypnea in COPD?
It indicates an increased respiratory rate often due to airflow obstruction ## Footnote Tachypnea is a common response to reduced oxygen exchange.
66
What is the nature of the course of COPD?
Chronic progressive with frequent acute exacerbations
67
What characterizes acute exacerbations of COPD?
Worsening dyspnea, increases in sputum purulence, and sputum volume
68
When are acute exacerbations of COPD more common?
During the winter months
69
What is the likely reason for increased acute exacerbations of COPD in winter?
Importance of viral pathogenesis
70
What is a frequent inciting agent in COPD exacerbations?
Viral infection
71
Name some commonly implicated viruses in COPD exacerbations.
* Rhinovirus * Respiratory syncytial virus (RSV) * Coronavirus * Influenza virus
72
What environmental factor is implicated in COPD exacerbations?
Air pollution
73
In what proportion of COPD exacerbations can no specific cause be identified?
One-third
74
True or False: Acute exacerbations of COPD always have a specific identifiable cause.
False
75
Fill in the blank: COPD exacerbations are characterized by worsening _______.
dyspnea
76
What characterizes the late stage of COPD?
Pneumonia, pulmonary hypertension, congestive heart failure/cor pulmonale, and chronic respiratory failure ## Footnote These conditions indicate severe complications associated with COPD.
77
Name some comorbid conditions associated with COPD.
* Pulmonary embolism * Pneumothorax * Lobar atelectasis * Pleural effusion * Arrhythmias ## Footnote These comorbidities can complicate the management of COPD.
78
True or False: Death due to COPD usually occurs during an exacerbation of illness.
True ## Footnote This exacerbation is often associated with acute respiratory failure.
79
Fill in the blank: Death due to COPD usually occurs during an exacerbation of illness in association with _______.
acute respiratory failure ## Footnote This indicates the critical nature of exacerbations in COPD patients.
80
What is a major complaint in patients with chronic bronchitis?
Chronic productive cough with copious mucopurulent sputum ## Footnote Patients often experience exacerbations due to frequent respiratory infections.
81
At what age does chronic bronchitis typically present?
Late 30's and 40's ## Footnote Symptoms often develop earlier compared to emphysema.
82
What physical characteristic is common in patients with chronic bronchitis?
Patients are frequently overweight and cyanotic ## Footnote They appear comfortable at rest despite symptoms.
83
What are common laboratory findings in chronic bronchitis?
Decreased PaO2 (45-60 mm Hg), elevated PaCO2 (50-60 mm Hg), elevated hematocrit and hemoglobin (15-18 mg/dL) ## Footnote These findings indicate hypoxia and hypercapnia.
84
What is a key difference in pulmonary function tests between chronic bronchitis and emphysema?
Chronic bronchitis shows airway obstruction on inspiration and expiration, while emphysema shows difficulty predominantly on expiration ## Footnote Total lung capacity is normal in chronic bronchitis but increased in emphysema.
85
What notable chest radiographic finding is associated with chronic bronchitis?
Increased bronchovascular markings and cardiomegaly ## Footnote Diaphragms are not flattened in chronic bronchitis.
86
What is the major complaint in patients with emphysema?
Severe dyspnea ## Footnote Cough is rare and sputum is scant and clear.
87
At what age does emphysema typically present?
After age 50 ## Footnote Symptoms develop later compared to chronic bronchitis.
88
What physical characteristics are common in patients with emphysema?
Patients are thin, barrel-chested, and may have recent weight loss ## Footnote Cyanosis and peripheral edema are uncommon in emphysema.
89
What is a typical laboratory finding for a patient with emphysema?
Normal to slightly decreased PaO2 (65-75 mm Hg) and normal PaCO2 unless FEV1 < 1 L ## Footnote Hematocrit and hemoglobin levels are usually normal (12-15 mg/dL).
90
What is a common pulmonary function test finding in emphysema?
Total lung capacity is increased, sometimes markedly so ## Footnote There is significant difficulty in expiration.
91
What chest radiographic finding is associated with emphysema?
Abnormal hyperinflation, increased anterior-posterior dimension, flat diaphragms ## Footnote Bullous changes may also be present.
92
What ECG changes may be observed in advanced COPD?
Sinus tachycardia, electrocardiographic abnormalities typical of cor pulmonale ## Footnote Supraventricular arrhythmias may also occur.
93
True or False: Arterial blood gas measurements are always necessary in COPD.
False ## Footnote They are unnecessary unless hypoxia or hypercapnia is suspected.
94
Fill in the blank: In chronic bronchitis, peripheral _______ is common.
edema
95
What is common in severe COPD regarding carbon dioxide retention?
Retention of carbon dioxide (CO2) is common ## Footnote This can lead to hypercapnia, which is an elevated partial pressure of CO2 in arterial blood.
96
What generally precedes CO2 retention in COPD patients?
Hypoxemia generally precedes CO2 retention ## Footnote Hypoxemia is a condition where there is a deficiency of oxygen in the blood.
97
Rarely occurs in patients with an FEV1 in excess of what percentage of the predicted normal value?
40% ## Footnote Patients with an FEV1 less than 30% of the predicted value commonly experience hypoxemia.
98
What is common when the FEV1 is less than 30% of the predicted value?
Hypoxemia is common ## Footnote This indicates a more severe stage of COPD.
99
What occurs in patients with chronic respiratory failure during acute exacerbations?
Worsening of acidemia occurs ## Footnote This is particularly noted in chronic bronchitis patients.
100
What is the reference standard for diagnosing COPD?
Pulmonary Function Tests (PFTs) / Spirometry ## Footnote These tests provide objective information for assessing disease progression and therapy results.
101
What is the primary physiologic abnormality in COPD as revealed by spirometry?
Accelerated decline in FEV1 ## Footnote Normal decline is approximately 30 mL/year, while in COPD it is nearly 60 mL/year.
102
What is the FEV1/FVC ratio in early stage COPD?
Less than 70% ## Footnote FEV1 may be normal to mildly decreased (100% to 80% of predicted value) at this stage.
103
How does FEV1 change as COPD becomes more advanced?
FEV1 continues to progressively decrease ## Footnote This indicates worsening disease severity.
104
What does FEV1 not correlate well with in individual patients?
Severity of dyspnea, exercise limitations, or health status ## Footnote Evaluation should also include symptom control and risk for adverse events.
105
What is the maximal volume of air that can be inhaled from the resting expiratory level?
Inspiratory capacity (IC) ## Footnote Inspiratory capacity is a key lung capacity measurement in respiratory physiology.
106
What is the volume of air in the lungs at maximal inflation called?
Total lung capacity (TLC) ## Footnote Total lung capacity is crucial for understanding lung function.
107
Define vital capacity (VC).
The volume of air an individual can breathe in upon full, forced inspiration after forced complete exhalation. ## Footnote Vital capacity is an important measure for assessing lung health.
108
What is the maximal volume of air exhaled from end-expiration called?
Expiratory reserve volume (ERV) ## Footnote Expiratory reserve volume helps determine the efficiency of breathing.
109
What is the maximal volume of air inhaled from end-inspiration?
Inspiratory reserve volume (IRV) ## Footnote Inspiratory reserve volume indicates the lung's capacity for additional air intake.
110
What is the volume of air remaining in the lungs after a maximal exhalation?
Residual volume (RV) ## Footnote Residual volume is important for maintaining gas exchange and preventing lung collapse.
111
What is the volume of air inhaled or exhaled during each respiratory cycle?
Tidal volume (VT) ## Footnote Tidal volume is a fundamental measurement in respiratory assessments.
112
Define forced vital capacity (FVC).
The total volume of air that can be exhaled during a maximal forced expiration effort. ## Footnote FVC is commonly used in spirometry to evaluate lung function.
113
What is the volume of air exhaled in the first second under force after a maximal inhalation?
Forced expiratory volume in one second (FEV1) ## Footnote FEV1 is a critical parameter for diagnosing obstructive and restrictive lung diseases.
114
What does the FEV1/FVC ratio represent?
The percentage of the FVC expired in one second ## Footnote This ratio is vital for interpreting spirometry results and assessing lung function.
115
What is a main clinical feature of emphysema?
Hyperinflation ## Footnote Hyperinflation is characterized by an increase in the volume of air in the lungs, leading to difficulty in breathing.
116
What are pathognomonic findings for emphysema?
Parenchymal bullae or subpleural blebs ## Footnote These structures are indicative of emphysema and are typically seen on imaging studies.
117
What may radiographs of patients with chronic bronchitis show?
Nonspecific peribronchial and perivascular markings ## Footnote These findings are not specific to chronic bronchitis and can be seen in other conditions as well.
118
What becomes evident in advanced disease of pulmonary hypertension?
Enlargement of central pulmonary arteries ## Footnote This enlargement can be observed through imaging techniques and indicates worsening pulmonary hypertension.
119
What is an effective method to estimate pulmonary artery pressure if pulmonary hypertension is suspected?
Doppler echocardiography ## Footnote Doppler echocardiography is a non-invasive imaging technique used to assess blood flow and pressures in the heart and pulmonary arteries.
120
What is the classification for Grade 0 COPD according to GOLD?
Spirometry still normal (FEV1/FVC ≥ 70%, FEV1 ≥ 80% of predicted value). Asymptomatic smoker or ex-smoker, or chronic cough and sputum production. ## Footnote Grade 0 indicates patients at risk but not yet symptomatic.
121
What characterizes Grade 1 - Mild COPD?
FEV1/FVC < 70%, but FEV1 ≥ 80% of predicted value. Shortness of breath from COPD with strenuous exercise. Usually chronic cough and sputum production. Patient may not be aware of abnormal lung function. ## Footnote Mild COPD is often not recognized by patients.
122
What defines Grade 2 - Moderate COPD?
FEV1/FVC < 70% with FEV1 between 50% to 79% of predicted value. Shortness of breath causing slower walking or stopping after 100 meters. Typically the stage when patients seek medical attention. ## Footnote Patients often experience dyspnea on exertion.
123
What are the characteristics of Grade 3 - Severe COPD?
FEV1/FVC < 70% with FEV1 between 30% to 49% of predicted value. Increased shortness of breath and repeated exacerbations. Patients may experience shortness of breath with minimal physical exertion. ## Footnote Quality of life is significantly impacted in this stage.
124
What criteria define Grade 4 - Very severe COPD?
FEV1/FVC < 70% with FEV1 < 30% of predicted value, presence of chronic respiratory failure, or clinical signs of right-sided heart failure due to cor pulmonale, or respiratory failure with PaO2 < 60 mmHg. ## Footnote Patients may still be classified as very severe even if FEV1 is > 30% if complications are present.
125
What is the primary determining criterion for COPD grading?
Post-bronchodilator FEV1. ## Footnote This measure is critical for assessing the severity of airflow limitation.
126
Fill in the blank: Grade 1 COPD has an FEV1 of _______.
≥ 80% of predicted value. ## Footnote This indicates mild airflow limitation.
127
True or False: Patients with Grade 0 COPD are symptomatic.
False. ## Footnote They may have chronic cough or sputum but are generally asymptomatic.
128
What is a common experience for patients in Grade 2 COPD?
Shortness of breath causing them to walk slower than peers or stop after 100 meters. ## Footnote This typically prompts patients to seek medical advice.
129
What is the COPD Assessment Test (CAT)?
A patient-completed instrument (questionnaire) that measures health status in COPD
130
What does the CAT assist patients and physicians in quantifying?
The impact of COPD on the patient’s health
131
On what scale is the CAT scored?
0 to 40 points
132
What does a CAT score change of 2 points suggest?
A meaningful difference in the degree of COPD severity/control
133
What CAT score indicates that a patient’s COPD symptoms may not be under optimum management?
10 or higher
134
How often does the CAT Development Steering Group recommend patients complete the CAT questionnaire?
Every 2 to 3 months
135
What additional assessments does the CAT complement?
* FEV1 measurement * Assessment of exacerbation risk * Degree of airway obstruction assessed using spirometry
136
What is the purpose of the CAT in clinical assessment?
To provide supplementary information to current management guidelines
137
True or False: The CAT is designed to be a complex and time-consuming measure.
False
138
Fill in the blank: The CAT provides a simple and reliable measure of _______ in COPD.
[health status]
139
What should be reviewed if a patient's CAT score is 10 or higher?
The patient’s COPD treatment plan
140
Clinical Implications and Patient Management Considerations Based on COPD Assessment Test (CAT) Score
141
What are the two main criteria for the GOLD Classification of COPD?
Severity of clinical COPD symptoms and risk for exacerbations.
142
What tools are used to assess the symptom burden in COPD patients?
CAT and mMRC dyspnea scores.
143
What defines a moderate COPD exacerbation?
Treated with short-acting bronchodilators plus antibiotics and/or systemic corticosteroids.
144
What defines a severe COPD exacerbation?
Treatment required an emergency room visit or hospitalization.
145
What is the approach to pharmacologic treatment for COPD?
Administered in a stepwise approach according to severity of disease and patient's tolerance for specific drugs.
146
What is the recommendation for patients with Grade 1 COPD?
Reduction of risk factors (influenza vaccine) and short-acting bronchodilator as needed.
147
What additional treatments are recommended for Grade 2 COPD?
Reduction of risk factors (influenza vaccine), short-acting bronchodilator as needed, long-acting bronchodilator(s), and cardiopulmonary rehabilitation.
148
What treatments are included for patients with Grade 3 COPD?
Reduction of risk factors (influenza vaccine), short-acting bronchodilator as needed, long-acting bronchodilator(s), cardiopulmonary rehabilitation, and inhaled corticosteroids if repeated exacerbations.
149
What is the management plan for Grade 4 COPD?
Reduction of risk factors (influenza vaccine), short-acting bronchodilator as needed, long-acting bronchodilator(s), cardiopulmonary rehabilitation, inhaled corticosteroids if repeated exacerbations, long-term oxygen therapy (if criteria met), and consideration of surgical options such as lung volume reduction surgery (LVRS) and lung transplantation. - O2 tank is a hint for severe COPD 24/7
150
True or False: Inhaled corticosteroids are only recommended for Grade 1 COPD.
False
151
Fill in the blank: For patients with COPD, the influenza vaccine is recommended for _______.
[reduction of risk factors]
152
What is the role of cardiopulmonary rehabilitation in COPD management?
Recommended for patients with moderate to very severe obstruction (Grade 2, 3, and 4).
153
What are the criteria for long-term oxygen therapy in COPD patients?
Criteria must be met (specific criteria not detailed in the text).
154
What surgical options may be considered for very severe COPD?
Lung volume reduction surgery (LVRS) and lung transplantation.
155
What is the single most important intervention for smokers with COPD?
Encourage smoking cessation ## Footnote Simply telling a patient they need to quit smoking succeeds only 5% of the time.
156
What is the role of vaccination in managing COPD?
Reduce infections that can lead to COPD exacerbations ## Footnote Vaccinations are a safe and effective modality for susceptible COPD patients.
157
Who should be offered the pneumococcal vaccine?
Patients older than 65 years or any patient with FEV1 less than 40% of predicted ## Footnote This recommendation applies to all COPD patients.
158
How often should the influenza vaccine be administered to COPD patients?
Annually ## Footnote All COPD patients should receive the influenza vaccine every year.
159
Is COVID-19 vaccination recommended for COPD patients?
Yes, it is strongly recommended ## Footnote COVID-19 vaccination is important for the health of COPD patients.
160
What is the only therapy documented to alter the natural history of COPD?
Supplemental oxygen in patients with resting hypoxemia ## Footnote Oxygen therapy is crucial for managing COPD in specific patient populations.
161
Which patients are particularly likely to benefit from oxygen therapy?
Patients with: * Resting hypoxemia * Pulmonary hypertension * Chronic cor pulmonale * Erythrocytosis (polycythemia) * Impaired cognitive function * Exercise intolerance * Nocturnal restlessness * Morning headache ## Footnote These conditions indicate a higher risk of complications due to low oxygen levels.
162
What is the PaO2 threshold for initiating oxygen therapy at rest in COPD patients?
PaO2 < 56 mmHg, or SaO2 ≤ 88% sustained for 6 minutes ## Footnote Additional criteria include PaO2 between 56-60 mmHg with evidence of cor pulmonale, pulmonary hypertension, heart failure, or polycythemia.
163
What is the oxygen saturation (SaO2) threshold for exertion to qualify for oxygen therapy?
SaO2 ≤ 87% on room air during a 6-minute walk sustained for at least 1 minute ## Footnote This assessment helps determine the need for supplemental oxygen during physical activity.
164
What nocturnal criteria indicate the need for oxygen therapy in COPD patients?
Nocturnal oximetry shows: * SaO2 ≤ 89% for > 20% of the night * SaO2 ≤ 89% for > 10% of the night with evidence of cor pulmonale, pulmonary hypertension, heart failure, or polycythemia ## Footnote Monitoring overnight oxygen levels is important for identifying nocturnal hypoxemia.
165
What are the proved benefits of oxygen therapy in advanced COPD?
Benefits include: * Longer survival * Reduced hospitalization needs * Better quality of life ## Footnote These benefits underscore the importance of appropriate oxygen therapy in managing advanced COPD.
166
How does survival correlate with the number of hours of oxygen therapy administered?
Survival is directly proportionate to the number of hours per day oxygen is administered ## Footnote Continuous oxygen therapy leads to significantly better outcomes compared to nocturnal use alone.
167
What is the estimated survival rate after 36 months for hypoxemic COPD patients on continuous oxygen therapy?
About 65% ## Footnote This survival rate is significantly higher than the 45% survival rate for those treated with only nocturnal oxygen.
168
What are the types of home oxygen systems available?
Home oxygen may be supplied by: * Liquid oxygen systems (LOX) * Compressed gas cylinders * Oxygen concentrators ## Footnote Having both stationary and portable systems enhances patient mobility and access to oxygen.
169
How many hours a day must oxygen by nasal cannulas be administered for most patients?
At least 15 hours a day ## Footnote Exceptions are made if therapy is intended only for exercise or sleep.
170
What flow rate of oxygen typically achieves a PaO2 greater than 55 mm Hg?
A flow rate of 1-3 L/min ## Footnote This flow rate is adequate for maintaining sufficient oxygen levels in most COPD patients.
171
What is the primary purpose of bronchodilators in COPD?
Improve symptoms, exercise tolerance, and overall health status ## Footnote Bronchodilators do not alter the decline in lung function characteristic of COPD
172
How should the aggressiveness of bronchodilator therapy be adjusted?
Matched to the severity of the patient's disease ## Footnote Discontinuation is recommended if there is no symptomatic improvement
173
Name a short-acting anticholinergic bronchodilator.
Ipratropium bromide ## Footnote Ipratropium bromide is superior to beta-2-selective agonist aerosols in patients with moderate to severe COPD
174
What is the recommended dosage for ipratropium bromide?
Two to four inhalations (18 μg each) every 6 hours ## Footnote Ipratropium bromide can also be administered as an inhalation solution by nebulizer
175
Why is ipratropium bromide preferred over short-acting beta-2-selective agonists?
Longer duration of action and absence of sympathomimetic side effects ## Footnote Side effects include tachycardia, tremor, and hypokalemia
176
What is the effect of combining ipratropium bromide and albuterol?
Slightly more effective in improving FEV1 than either agent alone ## Footnote However, it is not superior in improving symptoms
177
Name two types of long-acting bronchodilators.
Beta-2-selective agonists (LABA) and anticholinergics (LAMA) ## Footnote Examples: LABA - formoterol, salmeterol; LAMA - tiotropium, glycopyrrolate
178
What advantages do long-acting bronchodilators have over short-acting agents?
Equivalent or superior bronchodilation and established symptomatic benefits ## Footnote More expensive but may offer superior clinical efficacy in advanced disease
179
What are inhaled corticosteroids (ICS) used for in patients with COPD?
To reduce exacerbations in patients with moderate to severe COPD. ## Footnote Examples of ICS include fluticasone, budesonide, and triamcinolone.
180
What is the controversy surrounding the role of ICS in COPD?
While ICS may reduce exacerbations and improve self-reported functional status, they do not affect mortality or the decline in lung function. ## Footnote Multiple large clinical trials support these findings.
181
Should ICS be considered first-line therapy for stable COPD patients?
No, ICS should not be considered first-line therapy in stable COPD patients. ## Footnote ICS are usually reserved for patients with two or more exacerbations annually or FEV1 less than 50% of predicted.
182
What is the recommended treatment for patients with an acute exacerbation of COPD?
Short courses of systemic (oral) corticosteroids, such as prednisone, improve outcomes. ## Footnote Oral prednisone 40 mg/day for 10 to 14 days is generally effective.
183
What is the effect of extending corticosteroid treatment beyond 14 days for COPD exacerbations?
Extending treatment beyond 14 days confers no added benefit and increases the risk of adverse events.
184
Is COPD generally responsive to systemic corticosteroid therapy apart from acute exacerbations?
No, COPD is not generally responsive to systemic corticosteroid therapy.
185
What are the recommendations regarding long-term treatment of COPD with systemic corticosteroids?
Systemic corticosteroids are not recommended for long-term treatment of COPD due to the risks of adverse side effects.
186
What is Theophylline classified as?
A systemic methylxanthine bronchodilator ## Footnote It is used for treating COPD patients.
187
What line of treatment is Theophylline generally considered for COPD patients?
Fourth-line agent ## Footnote It is used when other treatments do not provide adequate symptom control.
188
What do the GOLD guidelines recommend regarding Theophylline?
Only as a last resort if other bronchodilators are unavailable or unaffordable ## Footnote This emphasizes the cautious approach to using Theophylline.
189
What is a significant concern associated with Theophylline?
Toxicity due to its narrow therapeutic window ## Footnote Long-term administration requires careful monitoring of serum levels.
190
What must be monitored during long-term administration of Theophylline?
Serum levels ## Footnote This is necessary to avoid toxicity.
191
Fill in the blank: Theophylline is a _______ bronchodilator.
systemic methylxanthine
192
True or False: Theophylline is a first-line treatment for COPD.
False ## Footnote It is considered a fourth-line treatment.
193
What are selective phosphodiesterase-4 (PDE-4) inhibitors used for?
They reduce exacerbations, improve dyspnea, and increase lung function in patients with moderate or severe COPD and chronic bronchitis with frequent exacerbations.
194
Name a specific PDE-4 inhibitor.
Roflumilast (Daliresp)
195
What is the proposed mechanism of action for PDE-4 inhibitors?
It is thought to be related to the effects of increased intracellular cyclic AMP in lung cells.
196
True or False: The specific mechanism of action of PDE-4 inhibitors is well defined.
False
197
Fill in the blank: Roflumilast is a selective phosphodiesterase-4 (PDE-4) _______.
inhibitor
198
What common bacteria cause chronic infection or colonization of the lower airways in patients with COPD?
S. pneumoniae, H. influenzae, M. catarrhalis ## Footnote These bacteria are frequently associated with chronic obstructive pulmonary disease (COPD) patients.
199
In patients with chronic severe airway obstruction, which additional bacteria may be prevalent?
P. aeruginosa ## Footnote P. aeruginosa is often associated with more severe forms of airway obstruction.
200
What are the three clinical situations in which antibiotics are prescribed for patients with COPD?
* As a prophylactic measure in patients with frequent exacerbations of chronic bronchitis * To treat an acute episode of bronchitis * To treat acute or severe COPD exacerbations ## Footnote Antibiotics play a key role in managing exacerbations and infections in COPD patients.
201
What is the purpose of Human alpha1-protease inhibitor?
Available for replacement therapy of emphysema due to congenital deficiency of alpha1-antiprotease. ## Footnote Alpha1-protease inhibitor is crucial for individuals with genetic deficiencies that lead to lung issues.
202
What types of therapy are considered expectorant/mucolytic/mucokinetic?
Examples include guaifenesin and N-acetylcysteine. ## Footnote These agents are used to help clear mucus from the respiratory tract.
203
True or False: Expectorant/mucolytic therapy is generally helpful in patients with COPD.
False. ## Footnote The efficacy of these agents in treating COPD remains controversial.
204
What outcomes have expectorant/mucolytic agents been shown to affect in COPD patients?
Decrease cough and chest discomfort. ## Footnote However, they do not improve dyspnea or lung function.
205
What adverse effect can expectorant/mucolytic agents sometimes elicit in COPD patients?
Bronchospasm. ## Footnote This side effect raises concerns about their use in individuals with respiratory conditions.
206
What is a primary component of cardiopulmonary rehabilitation?
Exercise training ## Footnote Exercise training includes both aerobic and resistance exercises tailored for patients with respiratory conditions.
207
What type of exercises should patients with COPD perform regularly?
Aerobic lower extremity endurance exercises ## Footnote These exercises enhance performance of daily activities and reduce dyspnea.
208
How does upper extremity exercise training benefit COPD patients?
Improves dyspnea and allows increased activities of daily living ## Footnote Activities requiring the use of upper extremities are enhanced through this training.
209
What are graded aerobic physical exercise programs?
Programs such as walking 20 minutes 3 times weekly or bicycling ## Footnote These programs help prevent deterioration of physical condition and improve daily activity capabilities.
210
What is the effect of inspiratory muscle training in COPD patients?
Reduces dyspnea and improves exercise tolerance, health status, and respiratory muscle strength in some patients ## Footnote This training involves inspiring against progressively larger resistive loads.
211
What is pursed-lip breathing?
A breathing technique that maintains resistance in the airway during exhalation ## Footnote It enhances oxygenation by employing partial closing of the lips to allow air to be expired slowly.
212
What is the purpose of abdominal breathing exercises for COPD patients?
To relieve fatigue of accessory muscles of respiration ## Footnote These exercises may help reduce dyspnea in some patients.
213
True or False: Exercise training is not necessary for patients with COPD.
False ## Footnote Exercise training is crucial for improving daily activities and reducing symptoms.
214
Fill in the blank: Graded aerobic physical exercise programs are helpful to prevent _______ of physical condition.
deterioration ## Footnote These programs are designed to maintain or improve physical capabilities.
215
What is a common condition in patients with predominately chronic bronchitis?
Increased mobilization of pulmonary secretions ## Footnote This is a key aspect of managing chronic bronchitis.
216
What methods can be used to accomplish increased mobilization of pulmonary secretions?
* Adequate systemic hydration * Effective cough training methods * Use of a hand-held flutter device (flutter valve) ## Footnote These methods are essential for improving airway clearance.
217
Fill in the blank: Increased mobilization of pulmonary secretions may be accomplished through the use of adequate systemic hydration, effective cough training methods, or use of a _______.
hand-held flutter device
218
True or False: A flutter valve is also known as a hand-held flutter device.
True ## Footnote The flutter valve aids in secretion clearance.
219
What are the requirements for lung transplantation?
Severe lung disease, limited activities of daily living, exhaustion of medical therapy, ambulatory status, potential for pulmonary rehabilitation, limited life expectancy without transplantation, adequate function of other organ systems, good social support system ## Footnote These requirements ensure that candidates are fit for the procedure and can benefit from the transplant.
220
What improvements are noted after lung transplantation?
Substantial improvements in pulmonary function and exercise performance ## Footnote These improvements indicate the effectiveness of lung transplantation in enhancing quality of life.
221
What is the two-year survival rate after lung transplantation for COPD?
75% ## Footnote This statistic highlights the success rate of lung transplantation specifically for patients with Chronic Obstructive Pulmonary Disease (COPD).
222
What are some complications associated with lung transplantation?
Rejection, opportunistic infection, obliterative bronchiolitis ## Footnote These complications can impact the long-term success and health of the transplanted lung.
223
True or False: A good social support system is one of the requirements for lung transplantation.
True ## Footnote A supportive environment is crucial for post-transplant recovery.
224
Fill-in-the-blank: The two-year survival rate after lung transplantation for _______ is 75%.
COPD ## Footnote COPD stands for Chronic Obstructive Pulmonary Disease.
225
What is a potential benefit of pulmonary rehabilitation after lung transplantation?
Improved exercise performance ## Footnote Pulmonary rehabilitation can enhance the recovery process and overall lung function.
226
What is Lung volume reduction surgery (LVRS)?
A surgical approach to relief of dyspnea and improvement in exercise tolerance in patients with advanced diffuse emphysema and lung hyperinflation. ## Footnote LVRS is also known as reduction pneumoplasty.
227
What percentage of lung volume is typically resected during LVRS?
20 - 30% of each lung from the upper zones. ## Footnote This resection is performed in patients with advanced diffuse emphysema.
228
What improvements can LVRS yield?
Modest improvements in: * Pulmonary function * Exercise performance * Dyspnea ## Footnote These improvements are particularly noted in patients with lung hyperinflation.
229
What is the optimal technique for volume reduction surgery?
Has not been determined. ## Footnote Both laser and stapling methods are being investigated.
230
What is a common postoperative complication of LVRS?
Prolonged air leaks occur in up to one-half of patients postoperatively. ## Footnote This complication can significantly affect recovery.
231
What are the mortality rates for LVRS in experienced centers?
Range from 4% to 10%. ## Footnote These rates are observed in centers with the largest experience with volume reduction surgery.
232
What is Bullectomy?
An older surgical procedure for palliation of severe dyspnea in patients with severe bullous emphysema. ## Footnote Bullectomy is aimed at improving breathing by removing large emphysematous bullae.
233
What does the surgeon do during a Bullectomy?
Removes a very large emphysematous bulla that demonstrates no ventilation or perfusion on lung scanning. ## Footnote This bulla compresses adjacent lung that has preserved function.
234
What condition is Bullectomy primarily used to treat?
Severe bullous emphysema. ## Footnote This condition leads to severe dyspnea, which Bullectomy aims to alleviate.
235
How is Bullectomy performed?
Can now be performed with a CO2 laser via thoracoscopy. ## Footnote This minimally invasive approach enhances recovery and reduces complications.
236
True or False: Bullectomy is a modern surgical procedure.
False. ## Footnote Bullectomy is considered an older procedure.
237
What are the common pathogens that increase the risk for recurrent pulmonary infections in patients with chronic bronchitis?
Haemophilus influenza, Streptococcus pneumoniae, and Moraxella catarrhalis ## Footnote These pathogens are often associated with exacerbations in chronic bronchitis.
238
What are common complications of advanced COPD?
Pulmonary hypertension, cor pulmonale, and chronic respiratory failure ## Footnote These complications can significantly affect the quality of life and prognosis in COPD patients.
239
Name two conditions that may worsen otherwise stable COPD.
Acute bronchitis and pneumonia ## Footnote Other conditions such as pulmonary embolization and concomitant left ventricular failure can also exacerbate COPD.
240
True or False: Spontaneous pneumothorax is common in patients with emphysema.
False ## Footnote It occurs in a small fraction of patients with emphysema.
241
What condition may cause hemoptysis in COPD patients?
Chronic bronchitis or bronchogenic carcinoma ## Footnote Hemoptysis should be evaluated carefully as it may indicate serious underlying conditions.
242
What is the asthma-COPD overlap syndrome (ACOS)?
A recently recognized clinical entity identifying a subgroup of smokers with COPD that shares pathogenic and inflammatory characteristics with asthma.
243
How is ACOS defined?
ACOS is defined as either: * Asthma with partially reversible airflow obstruction with or without emphysema or reduced DLco to < 80% predicted. * COPD with emphysema accompanied by reversible or partially reversible airflow obstruction, with or without environmental allergies or reduced DLco.
244
When should a diagnosis of ACOS be considered?
When a similar number of features listed for asthma and COPD are present.
245
Why is the definition for ACOS considered not very specific?
Because a more detailed classification of patients with overlapping features of asthma and COPD is needed.
246
What factors have studies used to diagnose ACOS?
Studies have used the pattern of symptoms, presence of incompletely reversible airflow obstruction, degree of bronchodilator reversibility, and bronchial hyperresponsiveness.
247
How does lung function and quality of life in ACOS patients compare to those with COPD or asthma alone?
Persons with ACOS have worse lung function, more respiratory symptoms, and a lower health-related quality of life than those with either disease alone.
248
What is the health care utilization trend for patients with ACOS?
Patients with ACOS experience more frequent health care utilization and more severe impairment than persons with COPD or asthma alone.
249
What does recent research indicate about the 15-year mortality for ACOS?
15-year mortality for ACOS was similar to that for COPD and worse than that for asthma and healthy controls.
250
Fill in the blank: ACOS is characterized by _______ airflow obstruction.
[partially reversible]
251
True or False: ACOS patients have a higher health-related quality of life than those with asthma or COPD alone.
False
252
What is the prevalence of obstructive sleep apnea (OSA) in patients with COPD?
OSA is prevalent in patients with COPD but is often undiagnosed and untreated.
253
What does COPD–OSA overlap syndrome refer to?
The coexistence of obstructive sleep apnea and chronic obstructive pulmonary disease.
254
What are the clinical characteristics of COPD–OSA overlap syndrome?
Severe clinical course characterized by profound nocturnal hypoxemia.
255
What are the risks associated with COPD–OSA overlap syndrome?
Higher risk of pulmonary hypertension and right-sided congestive heart failure.
256
True or False: COPD–OSA overlap syndrome is commonly diagnosed in patients.
False
257
What should be avoided in dental management for patients with COPD?
Anything that could further depress respiration ## Footnote Patients with COPD have compromised respiratory function, necessitating caution in treatment.
258
What coexisting conditions must be addressed in patients with COPD during dental management?
Congestive heart failure and/or hypertension ## Footnote These conditions are common in patients with COPD and affect dental care considerations.
259
What should be reviewed in a patient's medical history pertaining to COPD?
The time of original diagnosis, duration of disease, evidence of concurrent cardiovascular disease, present medications, history of surgical treatment, current clinical status, and factors that may exacerbate COPD. ## Footnote Concurrent cardiovascular diseases may include hypertension and congestive heart failure.
260
What is the significance of determining the time of original diagnosis and duration of disease in COPD patients?
It helps assess the progression and management of the disease. ## Footnote Understanding the timeline can inform treatment decisions and patient prognosis.
261
What should be assessed to determine the severity of a COPD patient's symptoms?
The presence and severity of symptoms such as dyspnea and orthopnea, possibly using a CAT assessment. ## Footnote CAT stands for COPD Assessment Test.
262
What constitutes a moderate exacerbation of COPD?
An exacerbation treated with short-acting bronchodilators plus antibiotics and/or systemic corticosteroids. ## Footnote Systemic corticosteroids can help reduce inflammation in the airways.
263
What is classified as a severe exacerbation of COPD?
An exacerbation that requires an emergency room visit or hospitalization. ## Footnote Severe exacerbations indicate a significant worsening of the patient's condition.
264
What recent tests should be obtained for a COPD patient?
Most recent pulmonary function tests (PFTs) and spirometry results. ## Footnote Arterial blood gas tests are useful but not routinely performed due to invasiveness.
265
What factors may exacerbate COPD?
The presence of an acute respiratory infection or continued tobacco smoking. ## Footnote Identifying these factors is crucial for effective management of the disease.
266
What precautions should be taken if a COPD patient has concurrent cardiovascular disease?
Appropriate precautions should be observed to manage both conditions safely. ## Footnote Cardiovascular disease can complicate the management of COPD.
267
Fill in the blank: The GOLD classification is used to determine the _______ of a COPD patient.
[severity] ## Footnote GOLD stands for Global Initiative for Chronic Obstructive Lung Disease.
268
What does elevated blood pressure, tachycardia, or irregular pulse rhythm indicate?
Toxic reactions or overdose of a sympathomimetic or anticholinergic bronchodilator, or methylxanthines. ## Footnote Symptoms may include anxiety, tremors, palpitations, dizziness, nausea, and vomiting.
269
List additional symptoms of toxicity or overdose of sympathomimetic or anticholinergic bronchodilators, or methylxanthines.
* Anxiety * Tremors * Palpitations * Dizziness * Nausea * Vomiting ## Footnote These symptoms are indicative of potential toxicity.
270
True or False: Nausea is a symptom of toxicity from methylxanthines.
True ## Footnote Nausea is one of the symptoms that can indicate toxicity.
271
Fill in the blank: Elevated blood pressure may indicate _______ reactions or overdose.
[sympathomimetic or anticholinergic] ## Footnote These types of reactions are linked to specific drug classes.
272
What is indicated for any patient with a COPD Assessment Test (CAT) score of 10 or higher?
A medical consult ## Footnote This score indicates a higher level of symptoms or impairment, warranting further evaluation.
273
What is the ASA Classification for Mild-to-Moderate COPD?
Consistent with GOLD stage 1 or early GOLD stage 2 COPD characterized by: * Dyspnea only on substantive exertion (mMRC grade 0 or 1) * FEV1 > 65% of predicted * SaO2 (on room air) > 95% * CAT # 20 ## Footnote mMRC grade 0: dyspnea occurs only with strenuous exercise; mMRC grade 1: dyspnea occurs when walking on level ground at a faster than normal pace or when walking up a slight hill.
274
What defines mMRC grade 2 dyspnea?
Patient walks slower than people of the same age on level ground because of dyspnea, or has to stop for breath when walking at their own pace on the level ground ## Footnote This is a key indicator for Moderate-to-Severe COPD classification.
275
What are the characteristics of Moderate-to-Severe COPD according to ASA Classification?
Consistent with late GOLD stage 2 or early GOLD stage 3 COPD characterized by: * mMRC grade 2 or 3 dyspnea * SaO2 (on room air): 91% - 95% * FEV1 40% to 65% of predicted * hypoxemia (PaO2 < 85 mm Hg) but no CO2 retention * any patient with COPD and a CAT = 21 - 30 ## Footnote mMRC grade 3 dyspnea: patient must stop for breath after walking about 100 meters or after a few minutes on level ground.
276
What indicates Severe-to-Very Severe COPD in the ASA Classification?
Consistent with late GOLD stage 3 or GOLD stage 4 COPD having one or more of the following: * Chronic respiratory failure or requiring chronic oxygen therapy at rest * Dyspnea at rest or mMRC grade 4 dyspnea * SaO2 (on room air) < 91% * FEV1 < 40% of predicted * CO2 retention (PaCO2 > 45 mm Hg) * any patient with COPD and a CAT > 30 ## Footnote mMRC grade 4 dyspnea: patient experiences dyspnea with minimal exertion such as while dressing or undressing.
277
Fill in the blank: mMRC grade 0 indicates dyspnea occurs only with _______.
[strenuous exercise]
278
What is the threshold for FEV1 in Mild-to-Moderate COPD?
FEV1 > 65% of predicted ## Footnote This is a critical measurement in assessing the severity of COPD.
279
True or False: A patient with SaO2 (on room air) < 91% is classified as Mild-to-Moderate COPD.
False ## Footnote This SaO2 level indicates Severe-to-Very Severe COPD.
280
What is the CAT score range for Moderate-to-Severe COPD?
CAT = 21 - 30 ## Footnote The CAT (COPD Assessment Test) is used to assess the impact of COPD on a patient's life.
281
What is the SaO2 threshold for Severe-to-Very Severe COPD?
SaO2 (on room air) < 91% ## Footnote This indicates a significant level of hypoxemia in COPD patients.
282
What does a CAT score greater than 30 indicate?
Severe-to-Very Severe COPD ## Footnote A high CAT score suggests a greater impact of COPD on the patient's quality of life.
283
What GOLD grades are generally acceptable for invasive dental treatment?
GOLD grades 0 to 3 ## Footnote GOLD stands for Global Initiative for Chronic Obstructive Lung Disease, which classifies the severity of COPD.
284
What ASA classes are generally acceptable for invasive dental treatment?
ASA class II or III ## Footnote ASA stands for American Society of Anesthesiologists, which classifies patients based on their physical status.
285
What should be avoided in patients with GOLD grade 4 COPD during dental treatment?
Physiologically stressful or complex invasive dental treatment ## Footnote This is particularly important in an outpatient setting.
286
Why must respiratory function be considered in patients with COPD during dental management?
Patients with COPD already have compromised respiratory function ## Footnote Efforts must focus on avoiding anything that could further depress respiration.
287
What cardiovascular conditions should be addressed in COPD patients during dental management?
Congestive heart failure and/or hypertension ## Footnote These conditions are common comorbidities in COPD patients.
288
What position should patients with a history of orthopnea be treated in?
Semisupine or upright chair position ## Footnote This helps avoid orthopnea and respiratory discomfort.
289
What type of local anesthetic blocks are not recommended for COPD patients?
Bilateral mandibular blocks or bilateral palatal blocks ## Footnote These may cause unpleasant choking sensations or difficulty swallowing.
290
What may contraindicate the use of local anesthetics in COPD patients?
Cardiovascular side effects from COPD medication ## Footnote Elevated blood pressure and/or tachycardia may require a reduction in anesthetic dosage.
291
How must nitrous oxide-oxygen (N2O-O2) inhalation sedation be used in COPD patients?
With caution, especially in those with emphysema or severe COPD ## Footnote High concentrations of N2O can lead to complications due to lung bullae.
292
What risk is associated with the use of nitrous oxide in patients with emphysema?
Rupturing bullae in the lungs and possibly causing pneumothorax ## Footnote This risk increases with high concentrations of nitrous oxide.
293
What is the effect of nitrous oxide on nitrogen in the body?
Displaces nitrogen, dissolves more in tissues, and expands when released ## Footnote This can create pressure if trapped in the lungs.
294
True or False: Invasive dental treatment is always safe for patients with GOLD grade 4 COPD.
False ## Footnote Patients with GOLD grade 4 COPD are at higher risk and require careful assessment.
295
What is the significance of PaCO2 > 45 mm Hg in severe COPD patients?
Indicates CO2 retention and hypoxic drive breathing ## Footnote Patients with severe COPD rely on low oxygen levels to drive their breathing rather than elevated CO2 levels.
296
What happens to respirations in severe COPD patients when exposed to high oxygen levels?
Decreased respirations (hypoventilation), possible apnea, and respiratory acidosis ## Footnote High oxygen levels can suppress the hypoxic drive in these patients.
297
What is the Haldane effect?
A rightward shift of the CO2 dissociation curve due to oxygenation of blood ## Footnote This effect increases the removal of CO2 from hemoglobin, reducing its affinity for CO2.
298
What is the consequence of the Haldane effect in severe COPD patients?
Increased PaCO2 due to inability to increase minute ventilation ## Footnote These patients cannot excrete CO2 effectively, leading to potential complications.
299
What is oxygen-induced hypercapnia?
Increased CO2 levels in the blood due to high oxygen levels ## Footnote This can occur in patients with severe COPD during N2O-O2 inhalation sedation.
300
What flow rate should be maintained during N2O-O2 inhalation sedation in severe COPD patients?
No more than 3L/min ## Footnote This helps avoid hypoxemia and reduces the risk of oxygen-induced hypercapnia.
301
What should the titrated oxygen saturation (SaO2) be for COPD patients during sedation?
88% to 92% ## Footnote This range helps avoid complications related to oxygen levels.
302
How much longer are induction and recovery times for COPD patients compared to healthy patients?
Twice as long ## Footnote This is important for anticipating sedation management in these patients.
303
What type of opioids have been shown to be effective in reducing breathlessness in COPD patients?
Low-dose opioids (such as oral sustained-release morphine, 10 mg, twice per day) ## Footnote These opioids do not cause respiratory depression or increase PaCO2.
304
What should be used with caution or avoided in patients with moderately-severe to severe COPD?
High-dose opioids ## Footnote High-dose opioids can cause respiratory depression and other adverse respiratory effects.
305
What is associated with increased adverse respiratory events among older adults with COPD?
Use of high-dose opioids and/or benzodiazepines alone or in combination ## Footnote This is due to opioids exacerbating respiratory depression and the impact of both on airway muscle tone and central chemosensitivity.
306
Which medications are preferred for pain management in COPD patients?
Opioids that are not strong respiratory depressants (e.g., codeine, tramadol) ## Footnote These should be administered at the lowest dose possible to achieve the desired analgesic effect.
307
What type of benzodiazepines may be used if sedative medication is required?
Low-dose oral benzodiazepines (e.g., alprazolam, triazolam) ## Footnote These are safer options for patients with respiratory concerns.
308
True or False: Low-dose opioids can cause respiratory depression in COPD patients.
False ## Footnote Low-dose opioids have been shown to reduce breathlessness without causing respiratory depression.
309
Fill in the blank: High-dose opioids are to be used with caution in patients with _______.
moderately-severe to severe COPD ## Footnote The risk of respiratory depression increases with high-dose opioids.
310
What are the potential effects of opioids and benzodiazepines on respiratory function?
Exacerbation of respiratory depression, adverse impact on upper airway muscle tone, central chemosensitivity, and arousability ## Footnote These effects heighten the risk of respiratory events.
311
What is the normal range for oxygen saturation (SaO2) in patients breathing room air?
97% to 100% ## Footnote A drop below this range indicates impaired oxygen exchange.
312
What SaO2 level indicates the need for intervention in patients with COPD?
Less than 91% ## Footnote This indicates impaired oxygen exchange.
313
What should be considered for patients with COPD presenting for dental treatment with an SaO2 less than 95%?
Supplemental humidified low-flow oxygen (2 to 3 L/min via nasal cannula) ## Footnote This is to support patients with low oxygen saturation.
314
What is the suggested target SaO2 range for most patients with COPD when using supplemental oxygen?
94 - 98% ## Footnote This range is recommended for effective oxygen therapy.
315
What is the target SaO2 for patients with very severe COPD at risk of oxygen-induced hypercapnic respiratory failure?
88 - 92% ## Footnote This target helps prevent complications related to oxygen therapy.
316
Why might the use of a rubber dam be problematic for some patients with severe COPD?
It may result in a feeling of compromised air supply ## Footnote This can cause anxiety or discomfort during dental procedures.
317
What can help alleviate the feeling of compromised air supply for patients using a rubber dam during dental procedures?
Low-flow humidified oxygen (2 to 3 L/min via nasal cannula) ## Footnote This can improve comfort and maintain adequate oxygen levels.
omed pt 2
flashcards
Decks in class (40)
# Cards
Brainscape helps you reach your goals faster, through stronger study habits.
© 2026 Bold Learning Solutions. Terms and Conditions